the aid library

LIST OPTIONS

Filter

2519

How Covid-19 is changing the world: a statistical perspective

UN DESA (2020) CC

COVID-19 has turned the world upside down. Everything has been impacted. How we live and interact with each other, how we work and communicate, how we move around and travel. Every aspect of our lives has been affected.

Download (92)

View PDF (133)

A Technical Brief for Breakthrough ACTION Field Teams – COVID-19 rumor tracking

Breathrough Action - For social and behavior change USAID (2020) C2

This is a short technical brief with important steps and resources on how country programs can track and address rumors around COVID-19 (as needed). The guide includes a number of great resources and links while also sharing nuggets from global, collective thinking around rumors.

Download (182)

View PDF (150)

Risk Communication and Community Engagement Guidance for Physical and Social Distancing

World Health Organisation (2020) C_WHO

Physical and social distancing measures are associated with limiting contact between people during disease outbreaks. These measures when applied are often enhanced by lockdowns or shutdowns as part of broader risk communication and community engagement strategies to halt the transmission of disease... more

Download (103)

View PDF (165)

COVID-19: Are children able to continue learning during school closures? A global analysis of the potential reach of remote learning policies using data from 100 countries

UN Children's Fund UNICEF (2020) C_UNICEF

Download (167)

View PDF (195)

Populations at risk: Implications of COVID-19 for hunger, migration and displacement, November 2020

International Organization for Migration IOM; World Food Programme WFP (2020) C1

The report – the first of its kind – shows how the pandemic has driven up food insecurity and increased vulnerability among migrants, families reliant on remittances and communities forced from their homes by conflict, violence and disasters. The two UN agencies warn the social and economic ... more

Analysing and using routine data to monitor the effects of COVID-19 on essential health services: practical guide for national and subnational decision-makers

World Health Organization WHO (2021) C_WHO

14 January 2021 This practical guide can be used to help countries monitor and analyse the impact of COVID-19 on essential health services to inform planning and decision-making. It provides practical recommendations on how to use key performance indicators to analyse changes in access to and deliv... more

Download (123)

View PDF (140)

COVID-19 Rumors and misinformation

USAID (2020) CC

A Technical Brief for Breakthrough ACTION Field Teams

External Link

Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019

GBD2019 Dementia Forecasting Coolaborators (2022) CC

Lancet Public health 2022 January 6, 2022 https://doi.org/10.1016/ S2468-2667(21)00249-8 Growth in the number of individuals living with dementia underscores the need for public health planning efforts and policy to address the needs of this group. Country-level estimates can be used to inform nati... more

Download (175)

View PDF (244)

Holding the line: communities as first responders to COVID-19 and emerging health threats

UNAIDS (2022) C_WHO

Zeroing in on Ending Hunger: Perspectives on the challenges, priorities, and critical next steps

Action against Hunger (2022) CC

English Analysis on World about Agriculture, Climate Change and Environment, Epidemic and more; published on 01 Feb 2022 by Action Against Hunger

Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map

Van Katwyk, S. R.; Grimshaw, J. M.; et al (2019) C2

BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc...e map can support governments in making evidence-informed decisions about implementing programs to reduce AMR, by identifying, describing, and assessing the full range of evaluated government policy options to reduce antimicrobial use in humans. METHODS AND FINDINGS: Seven databases were searched from inception to January 28, 2019, (MEDLINE, CINAHL, EMBASE, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science, and PubMed). We identified studies that (1) clearly described a government policy intervention aimed at reducing human antimicrobial use, and (2) applied a quantitative design to measure the impact. We found 69 unique evaluations of government policy interventions carried out across 4 of the 6 WHO regions. These evaluations included randomized controlled trials (n = 4), non-randomized controlled trials (n = 3), controlled before-and-after designs (n = 7), interrupted time series designs (n = 25), uncontrolled before-and-after designs (n = 18), descriptive designs (n = 10), and cohort designs (n = 2). From these we identified 17 unique policy options for governments to reduce the human use of antimicrobials. Many studies evaluated public awareness campaigns (n = 17) and antimicrobial guidelines (n = 13); however, others offered different policy options such as professional regulation, restricted reimbursement, pay for performance, and prescription requirements. Identifying these policies can inform the development of future policies and evaluations in different contexts and health systems. Limitations of our study include the possible omission of unpublished initiatives, and that policies not evaluated with respect to antimicrobial use have not been captured in this review. CONCLUSIONS: To our knowledge this is the first study to provide policy makers with synthesized evidence on specific government policy interventions addressing AMR. In the future, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published. more

Download (120)

View PDF (176)

Target product profile for a gambiense human African trypanosomiasis test to identify individuals to receive widened treatment

World Health Organization WHO (2022) C_WHO

The development of this target product profile (TPP) was led by the WHO Department of Control of Neglected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG) was form... more

External Link

Global mortality of snakebite envenoming between 1990 and 2019

Nature Communications (2022) CC

Snakebite envenoming affects millions of people worldwide annually and is a significant source of mortality. Preventing and treating the problem is complex and requires collaboration among the fields of public health, medicine, ecology, and laboratory science. After being removed from the category A... more

External Link

Vector-borne diseases: a handbook for pharmacists - Disease prevention, control, management and treatment

Gromek K., Hung M., Montero N. et al International Pharmaceutical Federation FIP (2020) C2

The Pharmaceutical Forum of the Americas (PFA) has previously published guidelines and organised campaigns for community pharmacists on the prevention, detection and control of arbovirus infections in 2018 with a grant from the FIP Foundation for Pharmacy Education and Research. Building on that exp... more

Download (137)

View PDF (140)

Integrating psychosocial interventions and support into HIV services for adolescents and young adults

World Health Organisation (WHO) (2023) C_WHO

Adolescence, defined as the period between 10 and 19 years of age, is a developmental stage during which many psychosocial and mental health challenges emerge. There is a well-established link between mental health and HIV outcomes. Adolescents and young adults living with HIV typically have additio... more

External Link

Funding the future of the HIV response

The Lancet Editorial (2022) CC

Substantial progress in the fight against HIV has been made over the past decade. Advances in HIV prevention, testing, and treatment have been matched by declines in HIV incidence and HIV-related deaths. The success of Botswana reaching the 95-95-95 targets, despite resource limitations, points to a... more

External Link

WHO Monographs On Selected Medicinal Plants - Volume 2

World Health Organization WHO (2007) C_WHO

• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States; • provide models to assist Member States in developing their own mono- graphs or formularies for these... more

Download (946)

View PDF (1752)

Training module on malaria control : case management. Guide for Tutors

WHO (2012)

Case Management; Guide for Tutors

Download (958)

View PDF (1813)

Integrating Mental Health into Primary Care

M. Funk; G. Ivbijaro World Health Organization; WONCA (2008) C_WHO

A Global Perspective

External Link

Dengue and severe dengue

World Health Organization WHO (2022) C_WHO

Dengue is a mosquito-borne viral disease that has rapidly spread to all regions of WHO in recent years. Dengue virus is transmitted by female mosquitoes mainly of the species Aedes aegypti and, to a lesser extent, Ae. albopictus. These mosquitoes are also vectors of chikungunya, yellow fever and Zik... more